Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-26 @ 1:35 AM
Study NCT ID:
NCT06011733
Status:
COMPLETED
Last Update Posted:
2025-03-10
First Post:
2023-08-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
Sponsor:
UCB Biopharma SRL
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-31
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-05
Completion Date Type:
ACTUAL
First Submit Date:
2023-08-21
First Submit QC Date:
None
Study First Post Date:
2023-08-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-07
Last Update Post Date:
2025-03-10
Last Update Post Date Type:
ACTUAL